title: Predicting the unpredictable: Recent structure-activity studies on peptide-based macrocycles.
abstract: Heterocycle-containing macrocycles are an emerging class of molecules that have therapeutic efficacy. Many biologically active natural products that have interesting biological properties fall into this class of molecules. The highly specific and selective biological activity is often attributed to the unique conformation of these macrocycles, which is affected by the elements of the macrocycles as well as its surroundings in biological systems. In this review, the structure-activity relationship studies of several recently developed biologically active heterocycle-containing macrocycles have been discussed in order to facilitate an understanding on how unpredictable structures can be controlled.
authors.affiliation: University of New South Wales, School of Chemistry, Sydney, NSW 2052, Australia.
authors.forename: Hendra
authors.initials: H
authors.lastname: Wahyudi
authors.affiliation: University of New South Wales, School of Chemistry, Sydney, NSW 2052, Australia.
authors.forename: Shelli R
authors.initials: SR
authors.lastname: McAlpine
mesh_terms: D000818:Animals; D000900:Anti-Bacterial Agents / Q000737:chemistry* / Q000494:pharmacology; D000970:Antineoplastic Agents / Q000737:chemistry* / Q000494:pharmacology; D000977:Antiparasitic Agents / Q000737:chemistry* / Q000494:pharmacology; D001419:Bacteria / Q000187:drug effects; D001424:Bacterial Infections / Q000188:drug therapy; D006801:Humans; D047028:Macrocyclic Compounds / Q000737:chemistry* / Q000494:pharmacology; D008968:Molecular Conformation; D009369:Neoplasms / Q000188:drug therapy; D010272:Parasitic Diseases / Q000188:drug therapy; D010455:Peptides / Q000737:chemistry* / Q000494:pharmacology; D013329:Structure-Activity Relationship
chemical_list: D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents; D000977:Antiparasitic Agents; D047028:Macrocyclic Compounds; D010455:Peptides
keywords: Biologically active; Conformation; Heterocycle; Macrocyclic peptides; Rationale design